Umaima Ahmad, co-founder and CEO of medtech startup, 52North on developing a new device to keep chemotherapy patients safe from infection.

A man from Cambridge is the first to join the surveillance part of a clinical trial that could see routine screening for oesophageal cancer introduced into the NHS, potentially halving deaths from this cancer every year.

A Cambridge-led trial testing a potential new treatment combination for post-menopausal women with hormone driven breast cancer reports positive findings at the international San Antonio Breast Cancer Symposium.

Cambridge survivor backs cancer plan to avoid 1,800 deaths a year in the East of England by 2040.